查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631518

酒糟治療市場規模、佔有率、趨勢分析報告：按藥物類別、給藥方式、地區和細分市場預測，2025-2030 年

Rosacea Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antibiotics, Alpha Agonists, Retinoids, Corticosteroids), By Mode Of Administration (Topical, Oral), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

酒糟治療市場的成長和趨勢

根據 Grand View Research, Inc. 的一份新報告，全球酒糟治療市場預計到 2030 年將達到 31.2 億美元。預計 2025 年至 2030 年期間複合年成長率為 7.1%。先進的配方和高發的疾病等多種因素預計將推動市場成長。

酒糟影響全球超過 4 億人，全球成人盛行率估計為 5%。目前接受治療的患者不到150萬，而且疾病的診斷非常晚。這種疾病在女性中比男性更為常見，一些研究發現飲酒與更年期症狀有關。由於沒有明確的治療方法方法，治療方法方案主要集中於疾病管理。

酒糟治療市場已經變得高度分散，由於多個專利到期，學名藥佔據了市場主導地位。酒糟是一種很容易被誤診的疾病，經常被誤診為痤瘡。藥品仿單標示外的使用導致了酒糟專用治療藥物的激烈競爭。

局部治療仍是主要治療方法。 2017年，外用產品佔了60%以上的市場佔有率。儘管預計在預測期內局部產品仍將保持對口服藥物的領先地位，但市場正在經歷模式轉移，其推動力是人們對組合產品的傾向日益增加。

酒糟的治療方案包括抗生素、α促效劑、類視色素、免疫抑制劑、皮質類固醇和抗高血壓藥物。抗生素被列為首選治療藥物，在 2017 年佔據主導地位，預計這一趨勢將持續到 2025 年。

酒糟治療市場的成長得益於 Rhofade、Mirvaso、Oracea、MetroGel、Noritate 和 Finacea 等主要產品的強勁商業性銷售。儘管學名藥的滲透是一個限制因素，但由於有前景的研發線產品即將面世，全球市場的未來前景樂觀。

酒糟治療市場報告重點

  • 由於抗生素作為酒糟的一線治療藥物的地位，它在 2024 年佔據了市場主導地位，收入佔有率為 51.3%。
  • 局部治療領域在 2024 年佔據了最大的收益佔有率，並佔據了市場主導地位。
  • 由於消費者意識高和醫療基礎設施先進等多種因素，北美酒糟治療市場預計將在 2024 年佔據 38.7% 的最高收入佔有率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3酒糟。

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第 4 章酒糟治療市場：藥物類別業務分析

  • 2024 年及 2030 年藥物類別市場佔有率
  • 藥品類別細分儀表板
  • 2018 年至 2030 年按藥物類別分類的市場規模、預測和趨勢分析
  • 抗生素
  • α-促效劑
  • 類視色素
  • 皮質類固醇
  • 免疫抑制劑
  • 其他

第 5 章酒糟治療市場：管理方法業務分析

  • 2024 年及 2030 年管理模式市場佔有率
  • 管理模式細分儀表板
  • 2018 年至 2030 年按交付方式分類的市場規模、預測與趨勢分析
  • 局部的
  • 口服

第 6 章酒糟治療市場：按地區分類的估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 按國家/地區，2018 年至 2030 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區，2018 年至 2030 年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區，2018 年至 2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • AbbVie Inc.
    • Bayer AG
    • Bausch Health Companies Inc.
    • Nestle Skin Health
    • Sol-Gel Technologies Ltd.
    • Mayne Pharma Group Limited
    • LEO Pharma A/S
    • Pfizer Inc.
    • Aclaris Therapeutics, Inc.
    • Galderma
Product Code: GVR-2-68038-739-1

Rosacea Treatment Market Growth & Trends:

The global rosacea treatment market size is expected to reach USD 3.12 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.1% from 2025 to 2030. Several factors such as an advanced formulations and high prevalence of the disease are forecasted to fuel the market growth.

Rosacea affects more than 400 million people worldwide and the global incidence among adults is estimated at 5%. Less than 1.5 million patients seek treatment, making it a highly underdiagnosed condition. This disease has a higher incidence in women than men, with several studies claiming a possible association between rosacea and menopause. In the absence of an absolute cure, treatment options are largely focused on management of the disease.

The market for rosacea treatment is majorly genericized due to multiple patent expiries, leading to a highly fragmented therapeutic landscape. Rosacea is an underdiagnosed condition and is frequently misdiagnosed as acne. Off-label use of therapeutics pose an intensely competitive space for rosacea-specific treatments.

Topical therapies remain the mainstay for treatment. Topical products captured more than 60% market share in 2017. Although topical items are expected to maintain their lead over oral medicines through the forecast period, the market is witnessing a paradigm shift supported by the increasing inclination towards combination products.

Therapeutic options available for rosacea treatment are antibiotics, alpha agonists, retinoids, immunosuppressants, corticosteroids, antihypertensive agents, and others. Antibiotics are prescribed for the first-line treatment, making them the dominant drug class in 2017-a trend expected to continue through 2025.

The rosacea treatment market growth is supported by strong commercial sales from key products such as Rhofade, Mirvaso, Oracea, MetroGel, Noritate, and Finacea. Although increased penetration of generic drugs is a constraining factor, the impending launch of several promising pipeline products indicate an optimistic future for the global market.

Rosacea Treatments Market Report Highlights:

  • The antibiotics segment dominated the market with a revenue share of 51.3% in 2024 due to their established role as first-line therapies for rosacea.
  • The topical segment dominated the market with the largest revenue share in 2024, which can be attributed to its convenience and effectiveness in treating localized symptoms.
  • North America rosacea treatment market held the highest revenue share of 38.7% in 2024 due to a combination of factors, including high consumer awareness and advanced healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Mode of Administration
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Rosacea Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Rosacea Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2030
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Billion)
  • 4.4. Antibiotics
    • 4.4.1. Antibiotics Market, 2018 - 2030 (USD Billion)
  • 4.5. Alpha Agonists
    • 4.5.1. Alpha Agonists Market, 2018 - 2030 (USD Billion)
  • 4.6. Retinoids
    • 4.6.1. Retinoids Market, 2018 - 2030 (USD Billion)
  • 4.7. Corticosteroids
    • 4.7.1. Corticosteroids Market, 2018 - 2030 (USD Billion)
  • 4.8. Immunosuppressants
    • 4.8.1. Immunosuppressants Market, 2018 - 2030 (USD Billion)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 5. Rosacea Treatment Market: Mode of Administration Business Analysis

  • 5.1. Mode of Administration Market Share, 2024 & 2030
  • 5.2. Mode of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Mode of Administration, 2018 to 2030 (USD Billion)
  • 5.4. Topical
    • 5.4.1. Topical Market, 2018 - 2030 (USD Billion)
  • 5.5. Oral
    • 5.5.1. Oral Market, 2018 - 2030 (USD Billion)

Chapter 6. Rosacea Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Canada Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. AbbVie Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bayer AG
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Bausch Health Companies Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Nestle Skin Health
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Sol-Gel Technologies Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Mayne Pharma Group Limited
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. LEO Pharma A/S
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Pfizer Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Aclaris Therapeutics, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Galderma
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global rosacea treatment market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 5 Global rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 6 North America rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 8 North America rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 9 U.S. rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 10 U.S. rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 11 Canada rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 12 Canada rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 13 Mexico rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 14 Mexico rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 15 Mexico rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 16 Europe rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 17 Europe rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 18 Europe rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 19 UK rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 20 UK rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 21 Germany rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 22 Germany rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 23 France rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 24 France rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 25 Italy rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 26 Italy rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 27 Spain rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 28 Spain rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 29 Norway rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 30 Norway rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 31 Denmark rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 32 Denmark rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 33 Sweden rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 34 Sweden rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 37 Asia Pacific rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 38 Japan rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 39 Japan rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 40 China rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 41 China rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 42 India rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 43 India rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 44 Australia rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 45 Australia rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 46 South Korea rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 47 South Korea rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 48 Thailand rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 49 Thailand rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 50 Latin America rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 51 Latin America rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 52 Latin America rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 53 Brazil rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 54 Brazil rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 55 Argentina rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 56 Argentina rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 57 Middle East & Africa rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 58 Middle East & Africa rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 59 Middle East & Africa rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 60 South Africa rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 61 South Africa rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 63 Saudi Arabia rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 64 UAE rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 65 UAE rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 66 Kuwait rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 67 Kuwait rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Rosacea treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug class outlook (USD Billion)
  • Fig. 10 Mode of administration outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 Rosacea treatment market dynamics
  • Fig. 13 Rosacea treatment market: Porter's five forces analysis
  • Fig. 14 Rosacea treatment market: PESTLE analysis
  • Fig. 15 Rosacea treatment market: Drug class segment dashboard
  • Fig. 16 Rosacea treatment market: Drug class market share analysis, 2024 & 2030
  • Fig. 17 Antibiotics market, 2018 - 2030 (USD Billion)
  • Fig. 18 Alpha agonists market, 2018 - 2030 (USD Billion)
  • Fig. 19 Retinoids market, 2018 - 2030 (USD Billion)
  • Fig. 20 Corticosteroids market, 2018 - 2030 (USD Billion)
  • Fig. 21 Immunosuppressants market, 2018 - 2030 (USD Billion)
  • Fig. 22 Others market, 2018 - 2030 (USD Billion)
  • Fig. 23 Rosacea treatment market: Mode of administration segment dashboard
  • Fig. 24 Rosacea treatment market: Mode of administration market share analysis, 2024 & 2030
  • Fig. 25 Topical market, 2018 - 2030 (USD Billion)
  • Fig. 26 Oral market, 2018 - 2030 (USD Billion)
  • Fig. 27 Rosacea treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 36 Europe rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 41 France country dynamics
  • Fig. 42 France rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 49 Denmark country dynamics
  • Fig. 50 Denmark rosacea treatment market, 2018 - 2030 (USD Billion
  • Fig. 51 Sweden country dynamics
  • Fig. 52 Sweden rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 53 Asia Pacific rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 56 China country dynamics
  • Fig. 57 China rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 58 India country dynamics
  • Fig. 59 India rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 60 South Korea country dynamics
  • Fig. 61 South Korea rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 62 Australia country dynamics
  • Fig. 63 Australia rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 66 Latin America rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 71 MEA rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework